Senolytics Plus TB Drugs Boost Survival in Infected Mice
Graded Preliminary — mouse study in young, aged and susceptible strains testing senolytics with TB therapy, yet the benefit is limited to animals and has not been tested in people.
This study suggests senolytic drugs may warrant testing as add-on therapy for tuberculosis in humans.
Tuberculosis triggers some lung cells to become senescent (zombie-like cells that won't die but cause damage). Researchers gave infected mice a senolytic cocktail of dasatinib, quercetin, and fisetin alongside standard TB treatment. The combo improved survival and reduced lung damage, especially in older mice.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchWhy Some Blood Vessels Age Faster Than Others, and What Might Slow It
Aging blood vessels may do more than raise heart risk, since this review argues they help drive wear and tear in distant organs too.
Cutting Calories May Calm the Inflammation Linked to Aging Cells
Scientists looked at how diet and supplements affect signs of aging cells in people.
Clearing Out Aging Cells Made Stem Cell Repair Work Far Better in Mice
Old, worn-out cells (called senescent cells) seem to block the body's natural repair work.